B
Workshop Agendas1
Raleigh Workshop
April 15, 2010
Renaissance Raleigh North Hills Hotel
Raleigh, North Carolina
Austin Workshop
April 27, 2010
AT&T Executive Education and Conference Center
Austin, Texas
Seattle Workshop
May 11, 2010
The Alexis Hotel Seattle
Seattle, Washington
Workshop Objectives
Following the recent, and ongoing, H1N1 vaccination campaigns, the objectives of this workshop are to
-
Examine innovative efforts used to distribute and administer vaccine and discuss how they may inform future efforts.
-
Examine how jurisdictions and providers interpreted and applied the CDC/ACIP recommendations for use of H1N1 vaccine.
-
Highlight successful approaches used by jurisdictions to develop and use innovative partnerships with traditional and non-traditional partners, such as community groups and the private sector, to enhance communication with the public and providers and to effectively distribute and administer vaccine.
-
Discuss strategies used to collect, monitor, evaluate, and use data during the H1N1 vaccination campaigns.
-
Discuss lessons learned and challenges that arose during the vaccination campaigns, and identify strategies to address these challenges for future emergency vaccination programs and other medical countermeasures dispensing campaigns.
Welcoming Remarks
Raleigh
JEFFREY ENGEL, North Carolina Department of Health and Human Services
Austin
DAVID LAKEY, Texas Department of State Health Services
Seattle
MARY SELECKY, Washington State Department of Health
Charge to Workshop Speakers and Participants
Raleigh, Seattle
JAY BUTLER, Workshop Co-Chair, Centers for Disease Control and Prevention
Austin, Seattle
JEFFREY DUCHIN, Workshop Co-Chair, Public Health–Seattle & King County, WA
SESSION I:
DISTRIBUTION STRATEGIES
Session Objectives
-
Provide an overview of strategies developed to receive, store, and distribute vaccine to participating H1N1 vaccine providers and administration sites in the community and strategies developed to administer vaccine:
-
-
How were providers and vaccinators recruited to participate in the H1N1 vaccination program? What partnerships were used? Did these partnerships rely on preexisting relationships and, if so, were they successful? Were new partnerships built?
-
What lessons were learned from the use of a centralized distribution mechanism?
-
Was vaccine distributed to administration sites through centralized healthcare system distribution sites or directly to administration sites?
-
How did the availability of specific vaccine formulations and indications impact distribution and administration strategies?
-
-
Discuss the successes, lessons learned, and how challenges might be addressed to help improve future emergency vaccination programs and other medical countermeasure campaigns.
Overview and Panel Objectives
Raleigh, Seattle
JAY BUTLER, Panel Chair, Centers for Disease Control and Prevention
Austin
JEFFREY DUCHIN, Panel Chair, Public Health–Seattle & King County, WA
Panel Remarks
Raleigh
SUSAN COOPER, Tennessee Department of Health
ANNE BAILOWITZ, Baltimore City Health Department, MD
JAMES TURNER, American College Health Association
AMANDA FULLER, North Carolina Department of Health and Human Services
GREG PRIMUTH, Walgreens
KIM BOGGESS, University of North Carolina at Chapel Hill and the American College of Obstetricians and Gynecologists
Austin
DON WILLIAMSON, Alabama Department of Public Health
JOHN REDD, Indian Health Service
ANN SALYER-CALDWELL, Tarrant County Public Health, TX
JAY BUECHE, H-E-B
JEANNE SHEFFIELD, University of Texas Southwestern Medical Center and the American College of Obstetricians and Gynecologists
WAYNE HACHEY, Office of the Assistant Secretary of Defense (Health Affairs)
Seattle
MARK HORTON, California Department of Public Health
DAVID FLEMING, Public Health–Seattle & King County, WA
JENNIFER ARNOLD, Washington State Pharmacy Association
NEIL KANESHIRO, Woodinville Pediatrics, WA, and the Washington State Chapter of the American Academy of Pediatrics
J. MICHAEL MUHM, The Boeing Company
LEONARDO PEREIRA, Oregon Health and Science University
Discussion with Panelists and Attendees
SESSION II:
PROGRAM IMPLEMENTATION AND VACCINE ADMINISTRATION
Session Objectives
-
Examine how jurisdictions and providers interpreted and applied the CDC/ACIP guidance:
-
Was vaccine administered sequentially or simultaneously to groups within the target population?
-
Was vaccine restricted to subgroups within the target population?
-
Was vaccine administered to groups outside the target population? If so, how and why was that decision made?
-
How was demand among target populations assessed?
-
What criteria were used for expanding beyond initial target populations?
-
What challenges arose in the interpretation, implementation, and regional coordination of CDC/ACIP recommendations
-
-
-
for H1N1 vaccination? Would a more restrictive, uniform approach have been desirable, or was the flexibility of the CDC/ACIP guidance important?
-
How did local interpretation of CDC/ACIP guidance influence strategy for vaccine administration?
-
-
Discuss lessons learned and how challenges might be addressed to help improve future emergency vaccination programs and other medical countermeasure campaigns.
Overview and Psanel Objectives
Raleigh, Austin
DAVID LAKEY, Panel Chair, Texas Department of State Health Services
Seattle
JEFFREY DUCHIN, Panel Chair, Public Health–Seattle & King County, WA
Panel Remarks
Raleigh
LAUREN SMITH, Massachusetts Department of Public Health
RAHUL GUPTA, Kanawha–Charleston Health Department, WV
BEVERLY PRITCHETT, Washington, DC, Department of Health
SCOTT NEEDLE, Collier Health Services, Inc., FL, and the American Academy of Pediatrics
CAROL CUNNINGHAM, Ohio Department of Public Safety
JOHN CARSON ROUNDS, Village Family Care, NC, and the American Academy of Family Physicians
Austin
JULIE MORITA, Chicago Department of Public Health, IL
PERRY BYNUM, Haltom City Fire/Rescue, TX
STEPHEN BLAIR, American Academy of Family Physicians
JASON TERK, Cook Children’s Physician Network, TX, and the Texas Pediatrics Society
TOM SHIMABUKURO, Centers for Disease Control and Prevention
Seattle
TERESA GARRETT, Utah Department of Health
KRISTEN EHRESMANN, Minnesota Department of Health
JOE FINKBONNER, Northwest Portland Area Indian Health Board
ALONZO PLOUGH, County of Los Angeles Department of Public Health, CA
DAVID GROSSMAN, Group Health Cooperative, WA
Discussion with Panelists and Attendees
SESSION III:
COMMUNICATION STRATEGIES
Session Objectives
-
Provide an overview of strategies used by communities to inform the general public, vulnerable populations, select target populations, and priority workforce (e.g., healthcare providers and first responders) about the threat of the pandemic and the availability of and eligibility for vaccine:
-
What strategies were successful and unsuccessful in developing and delivering communication messages for specific segments of the population?
-
What particular challenges were associated with different population groups?
-
Given the challenges of vaccine availability, what strategies were used to manage expectations of providers, target populations, and the public?
-
How were target populations informed about vaccine availability?
-
How were target populations assured about vaccine safety?
-
-
Discuss lessons learned and how challenges might be addressed to help improve future emergency vaccination programs and other medical countermeasure campaigns.
Overview and Panel Objectives
Raleigh, Seattle
JACK HERRMANN, Panel Chair, National Association of County and City Health Officials
Austin
KRISTINE SHEEDY, Panel Chair, Centers for Disease Control and Prevention
Panel Remarks
Raleigh
KARYL RATTAY, Delaware Department of Health and Social Services
PAMELA BLACKWELL, Cobb & Douglas Public Health, GA
DAVID BROWN, The Washington Post
BENJAMIN RACKLEY, Tuskegee Area Health Education Center, Inc., AL
JULIE HENRY, North Carolina Department of Health and Human Services
Austin
PAUL HALVERSON, Arkansas Department of Health
LESLEA BENNETT-WEBB, Oklahoma State Department of Health
CANDACE CRAUSE, Champaign-Urbana Public Health District, IL
GREG BOGDAN, Rocky Mountain Poison & Drug Center at Denver Health, CO
MAGGIE FOX, Reuters
Seattle
SELENA MANYCHILDREN, Navajo Division of Health
MOHAMED SHEIKH HASSAN, Afrique Service Center, WA
TIFFANY SUTTER, California Department of Public Health
GREG WILKINSON, State of Alaska Health and Social Services
Discussion with Panelists and Attendees
SESSION IV:
MONITORING, IMPACT, AND EVALUATION
Session Objectives
-
Examine and discuss strategies that were used to collect, monitor, evaluate, and use data during the H1N1 vaccination campaign:
-
What data were used to ascertain the impact and reach of this immunization effort?
-
What data would have been especially helpful but were not available?
-
-
-
How can data be gathered and analyzed quickly during an event in order to drive policy immediately?
-
Was it possible to assess vaccine coverage? What levels of coverage were achieved among different populations, and did the H1N1 vaccination campaign adequately immunize persons in the ACIP target groups?
-
What data were used or would be most useful to improve immunization rates for persons in the target groups and in the general population?
-
-
Discuss lessons learned and how monitoring, impact, and evaluation can be improved for future emergency vaccination programs and other medical countermeasure campaigns.
Overview and Panel Objectives
Raleigh
CATHY SLEMP, Panel Chair, West Virginia Department of Health and Human Resources
Austin
B. TILMAN JOLLY, Panel Chair, Department of Homeland Security
Seattle
BETH BELL, Panel Chair, Centers for Disease Control and Prevention
Panel Remarks
Raleigh
KAREN REMLEY, Virginia Department of Health
DAVID GRUBER, New Jersey Department of Health and Senior Services
BETH MALDIN MORGENTHAU, New York City Department of Health and Mental Hygiene, NY
LAURA WILLIAMS, Boston EMS, MA
PASCALE WORTLEY, Centers for Disease Control and Prevention
BETH ROWE-WEST, Association of Immunization Managers
Austin
DANIEL HOPFENSPERGER, Wisconsin Department of Health Services
EDUARDO SANCHEZ, Blue Cross and Blue Shield of Texas
ANGIEHAGY, City of Milwaukee Health Department, WI
PAMELA FALK, University of Texas Medical Branch at Galveston
Seattle
CATHY SLEMP, West Virginia Department of Health and Human Resources
ANTHONY L.-T. CHEN, Tacoma–Pierce County Health Department, WA
LAURENE MASCOLA, Los Angeles County Department of Public Health, CA
RICHARD JUSTMAN, UnitedHealth Group
Discussion with Panelists and Attendees
SESSION V:
GENERAL DISCUSSION WITH WORKSHOP PARTICIPANTS AND ATTENDEES
Session Objectives
Discuss opportunities and constraints identified during the workshop that may help inform future efforts to administer vaccine and dispense medical countermeasures. As future campaigns are developed and time-dependent scenarios considered, what improvements are needed to ensure a safe, robust, and timely response?
Panel Discussion: Implementing the Lessons Learned
Raleigh
LISA KOONIN, Panel Chair, Centers for Disease Control and Prevention
CATHY SLEMP, West Virginia Department of Health and Human Resources
PAMELA BLACKWELL, Cobb & Douglas Public Health, GA
SCOTT NEEDLE, Collier Health Services Inc., FL, and the American Academy of Pediatrics
Austin
JEFFREY DUCHIN, Panel Co-Chair, Public Health–Seattle & King County, WA
LISA KOONIN, Panel Co-Chair, Centers for Disease Control and Prevention
TOBY MERLIN, Centers for Disease Control and Prevention
DAVID LAKEY, Texas Department of State Health Services
Seattle
TOBY MERLIN, Panel Chair, Centers for Disease Control and Prevention
JAMES BLUMENSTOCK, Association of State and Territorial Health Officials
CATHY SLEMP, West Virginia Department of Health and Human Resources
JACK HERRMANN, National Association of County and City Health Officials
Moderated Discussion with Panelists and Attendees
-
What new ideas have surfaced in this meeting today that should be explored further?
-
Were lessons learned during the pandemic response that could enhance efforts to reduce the burden of seasonal flu in future years?
-
Were any examples discussed that could be implemented immediately to improve the efficiency and effectiveness of the vaccine administration system?
-
What further evaluation questions remain?
Closing Remarks
Raleigh
JAY BUTLER, Workshop Co-Chair, Centers for Disease Control and Prevention
Austin, Seattle
JEFFREY DUCHIN, Workshop Co-Chair, Public Health–Seattle & King County, WA
